Pluristem Therapeutics
Why Robinhood?
You can watch PSTI and buy or sell other stocks, ETFs, and their options commission-free!About PSTI
Pluri, Inc. is a clinical stage company, which engages in cell therapy development. It develops placenta-based cell therapy product candidates for the treatment of multiple ischemic, inflammatory, and hematologic conditions.
PSTI Key Statistics
Stock Snapshot
The current Pluristem Therapeutics(PSTI) stock price is $3.85, with a market capitalization of 40.16M. The stock trades at a price-to-earnings (P/E) ratio of -0.60.
On 2026-08-25, Pluristem Therapeutics(PSTI) shares started trading at —, with intraday highs of — and lows of —.
Trading activity shows a volume of 0, compared to an average daily volume of 62K.
The stock's 52-week range extends from a low of $1.59 to a high of $5.68.
The stock's 52-week range extends from a low of $1.59 to a high of $5.68.
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.